Hayat Pharmaceutical Industries Co

Last Updated:
  • 2.62 JOD
  • 0.00
  • 0.00%
الحياة للصناعات الدوائية
الحياة
Symbol : HPIC
ISIN : JO4121011012
52-Week Range : 2.40 - 2.63
Turnover Ratio : 0.02
Market : Amman Stock Exchange
Sector : Industrial
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Basic Information

  • Activity :
    Hayat Pharmaceutical Industries Co (known as: Hayat) is a public company, listed on Amman Stock Exchange since May 2006. Hayat operates within the pharmaceuticals, biotechnology & life sciences sector...
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    JO4121011012
  • Contact Person :
  • Established On:
    03-Apr-1994
  • Stock Listing On :
    01-May-2006
  • No of Employees :
    208 Employees as of 2019
  • Outstanding Shares :
    9,500,000
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
  • Authorized Capital :

Indices Membership

Action Date Index Provider
Join 2012 ASE General Index Amman Stock Exchange
Join 2006 Industrial Amman Stock Exchange
Join 2006 Pharmaceutical and Medical Industries
Hayat Pharmaceutical Industries Co
Nile Street - Rejaib - PO Box 1564 Amman 11118 Jordan
T : +962 6 4162607
F : +962 6 4163016
www.hayatpharma.com
info@hayatpharma.com

Management

Title Name As Of
Chairman: Omar Shahroor 2023
Deputy Chairman: Maher Al Kurdi 2018
Board Member: Raghda Al Kordi 2014
Ezz El Din Katekhda 2024
Mowaffaq Ismaiel 2014
Ammar Malhas 2014
Walid Shehadeh 2014

Reports

Date Title File
2024 Hayat Quarterly Financials Report Q3 2024
2024 Hayat Quarterly Financials Report Q2 2024
2024 Hayat Quarterly Financials Report Q1 2024
2024 Hayat Annual Financials Report 2023
2023 Hayat Quarterly Financials Report Q2 2023
2023 Hayat Quarterly Financials Report Q1 2023
2023 Hayat Annual Financials Report 2022
2022 Hayat Quarterly Financials Report Q3 2022
2022 Hayat Quarterly Financials Report Q2 2022
2022 Hayat Quarterly Financials Report Q1 2022
2022 Hayat Quarterly Financials Report Q1 2022
Check our coverage for